Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Effects of phage-based treatments against an OXA-48-producing Klebsiella pneumoniae isolate in simulated human gut microbiomes

  • Ferriol-González, Celia
  • Hernanz-Grimalt, Ana
  • Valdivia, Carlos
  • García-Cobos, Silvia
  • Domingo-Calap, Pilar
  • Heredia Gutiérrez, Ana Belén|||0000-0001-6629-9779
  • García Hernández, Jorge|||0000-0003-1258-6128
  • Andrés Grau, Ana María|||0000-0002-6132-3167
[EN] Background: Carbapenem-resistant K. pneumoniae (CRKP) is one of the most prevalent antimicrobial-resistant pathogens, primarily causing nosocomial infections. These bacteria often colonize the gut microbiota, and their carriage is an important risk factor for later infection. Phages are an emerging alternative against antimicrobial-resistant bacteria causing infections, but their effect on the microbiota is still poorly understood. Results: Here, we simulated the colonization of the gut microbiota of three healthy adults by an OXA-48-producing CRKP isolate in a dynamic in vitro colonic simulator (SHIME (R)) and evaluated the effect of phage treatments in reducing CRKP load. Phage growth dynamics in the system seemed to be dependent on phage host range, rather than the donor's microbiota composition. Additionally, phage treatment significantly reduced K. pneumoniae load and bla(OXA-48) copy number, highlighting its potential for controlling the CRKP population. Importantly, phage treatment did not affect the microbiota diversity of any of the three donors, suggesting it has a minimal impact on the microbiome. Conclusions: Our results support the potential of phage-based strategies for the biocontrol of CRKP in the gut microbiota, reducing the abundance of this pathogen in its main reservoirs and preventing nosocomial CRKP infections., This research was funded by project PID2023-150309OB-I00 (Ministerio de Ciencia, Innovacion y Universidades) awarded to P.D.-C. C.F.-G., A.H.-G., and C.V. were funded by PhD fellowships Atraccio de Talent UV-INV_PREDOC-1913324 (Universitat de Valencia), Proyectos de I + D + i Retos Investigacion PREP2023-001677 (Ministerio de Ciencia, Innovacion y Universidades), and CIACIF/2023/126 (Generalitat Valenciana), respectively. P.D.-C. was financially supported by a Ramon y Cajal contract RYC2019-028015-I funded by MCIN/AEI/https://doi.org/10.13039/501100011033, ESF Invest in your future. Written informed consent was obtained from three donors who were rigorously informed about the aims and procedures of this study and consented to participate.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Effects of phage-based treatments against an OXA-48-producing Klebsiella pneumoniae isolate in simulated human gut microbiomes

  • Ferriol-González, Celia
  • Hernanz-Grimalt, Ana
  • Valdivia, Carlos
  • García-Cobos, Silvia
  • Heredia, Ana
  • García-Hernández, Jorge
  • Andrés, Ana
  • Domingo-Calap, Pilar
[Background] Carbapenem-resistant K. pneumoniae (CRKP) is one of the most prevalent antimicrobial-resistant pathogens, primarily causing nosocomial infections. These bacteria often colonize the gut microbiota, and their carriage is an important risk factor for later infection. Phages are an emerging alternative against antimicrobial-resistant bacteria causing infections, but their effect on the microbiota is still poorly understood., [Results] Here, we simulated the colonization of the gut microbiota of three healthy adults by an OXA-48-producing CRKP isolate in a dynamic in vitro colonic simulator (SHIME®) and evaluated the effect of phage treatments in reducing CRKP load. Phage growth dynamics in the system seemed to be dependent on phage host range, rather than the donor’s microbiota composition. Additionally, phage treatment significantly reduced K. pneumoniae load and blaOXA-48 copy number, highlighting its potential for controlling the CRKP population. Importantly, phage treatment did not affect the microbiota diversity of any of the three donors, suggesting it has a minimal impact on the microbiome., [Conclusions] Our results support the potential of phage-based strategies for the biocontrol of CRKP in the gut microbiota, reducing the abundance of this pathogen in its main reservoirs and preventing nosocomial CRKP infections., This research was funded by project PID2023-150309OB-I00 (Ministerio de Ciencia, Innovación y Universidades) awarded to P.D.-C. C.F.-G., A.H.-G., and C.V. were funded by PhD fellowships Atracció de Talent UV-INV_PREDOC-1913324 (Universitat de València), Proyectos de I + D + i Retos Investigación PREP2023-001677 (Ministerio de Ciencia, Innovación y Universidades), and CIACIF/2023/126 (Generalitat Valenciana), respectively. P.D.-C. was financially supported by a Ramón y Cajal contract RYC2019-028015-I funded by MCIN/AEI/https://doi.org/10.13039/501100011033, ESF Invest in your future., Peer reviewed